Genetic Biomarkers and Individual Response: Who Benefits Most from Which Option Not all GLP-1 medications work equally for every patient
Compared to the control, T2DM patients treated with semaglutide 1 mg saw a reduction of 29 mg/dL (22%) for pre-prandial glucose, 74 mg/dL (36%) for 2-h postprandial glucose, and 30 mg/dL (22%) for mean 24-h glucose concentration [26]
Join as a member Related Articles and Topics: Short-chain Acyl-CoA Dehydrogenase Deficiency Very Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD) GLP-1: Genetic Variants Related to GLP1 Weight Loss Drugs References: Blois, B., et al
Bottom line: if your draw is under 3 units, use less BAC water
A detailed understanding of the mechanisms of intracellular redox homeostasis and their connection to disease depends on our ability to quantify, among other parameters, changes in GSH concentration in specific organelles